

Nu Skin vs USANA
Nu Skin Enterprises sells personal care products and nutritional supplements through a direct sales network that spans dozens of countries and relies on a large independent distributor force, while USANA Health Sciences distributes nutritional supplements and personal care products through a similar multi-level direct sales model with heavy concentration in Asian markets. Both companies live or die by their ability to recruit and retain active distributors, which makes their revenue streams highly sensitive to distributor sentiment and regulatory scrutiny. The Nu Skin vs USANA comparison investigates active customer trends, revenue per distributor, China exposure, and which business model shows greater resilience in a challenging direct sales environment.
Nu Skin Enterprises sells personal care products and nutritional supplements through a direct sales network that spans dozens of countries and relies on a large independent distributor force, while US...
Investment Analysis

Nu Skin
NUS
Pros
- Reported a solid Q3 2025 revenue of $364.2 million with adjusted EPS of $0.34, exceeding EPS expectations and maintaining guidance.
- Core business maintains a strong gross margin of 70.5% and has successfully reduced selling expenses to 35.8%, improving operational efficiency.
- Strong cash balance of $251.7 million supports liquidity, with growth initiatives underway including a new product preview and India market entry planned.
Considerations
- Q3 revenue came in slightly below analyst estimates, indicating potential top-line growth challenges.
- The company’s market capitalization has declined significantly over the past decades, reflecting long-term valuation pressures.
- Forward price-to-earnings ratio near 9 with a neutral analyst rating suggests limited near-term valuation upside.

USANA
USNA
Pros
- USANA Health Sciences operates in the growing health and wellness sector with a strong nutritional supplement portfolio.
- Reported revenue growth in recent periods supported by expanding international presence, particularly in Asia.
- Maintains a focused direct selling model, which can enhance customer loyalty and reduce reliance on traditional retail channels.
Considerations
- Faces regulatory scrutiny risks common in the nutritional supplement industry, which could impact operations and reputation.
- Highly competitive market with significant pressure from other established wellness and supplement companies may constrain growth.
- Stock valuation appears elevated relative to some peers, potentially reflecting stretched expectations for near-term growth.
Buy NUS or USNA in Nemo
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.


